Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy (French SCS Registry)
CompletedNCT01778426
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Observational study to evaluate the long term efficacy of Spinal Cord Stimulation (SCS) over 2 years following SCS implant. This study is requested by French Health Authorities for reimbursement renewal, to maintain reimbursement for SCS in approved indication in France.
Study details
- Official title
- Post-reimbursement Study to Follow Spinal Neurostimulator Devices for Pain Therapy
- Conditions
- Sponsor
- MedtronicNeuro
- Collaborators
- Medtronic Cardiac Rhythm and Heart Failure
- Start date
- 2012-01
- Primary completion
- 2016-06
- Sex
- All
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient indicated for Spinal Cord Stimulation (pain therapy) * Patient implanted for less than 3 months or hospitalized for the implant of a Medtronic neurostimulator including: * primary implant with Spinal Cord Stimulation indication and positive test of stimulation or * device replacement of a Medtronic neurostimulator used for Pain Therapy * Evaluation of usual pain in the back, upper and lower limbs using a visual analogic scale must be available for the 3 days preceding implant. * Treatments must also be available * Patient read and signed the data release form Exclusion Criteria: * Patient declined participation * Patient is not available for follow up * Stimulation of other body part than spinal
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01778426